KKR Entities Acquire Significant Stake in Australian Clinical Labs
Company Announcements

KKR Entities Acquire Significant Stake in Australian Clinical Labs

Australian Clinical Labs Ltd (AU:ACL) has released an update.

KKR Entities, including Comet Asia Holdings and KKR Asia III Fund, have become significant shareholders in Australian Clinical Labs Ltd, acquiring a 5.12% voting power through over 10 million fully paid ordinary shares. This development marks a notable investment move, potentially impacting the company’s future market dynamics.

For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App